Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Market Trading Guide: Buy Nippon Life, Bharat Dynamics on Friday for gains up to 14%
Nifty ended marginally lower despite showing a consolidation breakout and improving technical indicators. Analysts expect bullish momentum to continue with upside potential in the near term. Nippon Life India Asset Management and Bharat Dynamics were highlighted as attractive trading opportunities based on strong chart patterns.
Raymond Q4 Profit Slips Sharply | Nifty Pharma Hits 52-wk High | Top Buzzing Stocks Today - Equitymaster
Raymond Q4 Profit Slips Sharply | Nifty Pharma Hits 52-wk High | Top Buzzing Stocks TodayEquitymaster
Raymond Q4 Profit Slips Sharply | Nifty Pharma Hits 52-wk High | Top Buzzing Stocks Today - Equitymaster
Raymond Q4 Profit Slips Sharply | Nifty Pharma Hits 52-wk High | Top Buzzing Stocks TodayEquitymaster
Ahead of Market: 10 things that will decide stock market action on Thursday
Domestic equities surged as crude oil slipped below $100 and US-India trade optimism boosted sentiment. Nifty and Sensex gained over 1%, led by banking, auto and pharma stocks, while global markets also strengthened amid easing geopolitical concerns and positive momentum signals
Individual investors sold Rs 13,000 crore worth stocks, but Zerodha clients kept buying: Nithin Kamath
Retail investors sold equities, but Zerodha clients bought heavily, highlighting divergence. Overall, direct retail ownership declined while mutual fund holdings hit record highs, reflecting a structural shift toward professionally managed investments and rising domestic institutional dominance in Indian equity markets
Baroda BNP Paribas MF sees easing crude boosting rate-sensitive stocks, chemicals
Baroda BNP Paribas Mutual Fund Senior Fund Manager Jitendra Sriram said softer crude prices could improve sentiment for India and support interest rate-sensitive sectors. He believes refining, oil marketing and select specialty chemical companies may benefit if West Asia tensions ease. Sriram also cautioned that higher raw material and logistics costs may pressure corporate earnings over the next few quarters despite resilient recent results. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Ruchit Jain of Motilal Oswal suggests Granules India, Nippon Life, and SRF shares to buy for the short term
The Nifty 50 and Sensex increased on May 6, supported by a government credit guarantee scheme for businesses. Investor sentiment improved due to positive earnings reports and falling oil prices, suggesting resilience in markets despite recent challenges.
Divis Laboratories Ltd gains for third straight session
Divis Laboratories Ltd is quoting at Rs 6722, up 1.07% on the day as on 12:49 IST on the NSE. The stock is up 9.34% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.
Mankind Pharma Ltd spurts 1.46%, up for third straight session
Mankind Pharma Ltd is quoting at Rs 2353.3, up 1.46% on the day as on 12:49 IST on the NSE. The stock is down 3.25% in last one year as compared to a 1.62% fall in NIFTY and a 12.19% fall in the Nifty Pharma index.
Torrent Pharmaceuticals Ltd up for third consecutive session
Torrent Pharmaceuticals Ltd is quoting at Rs 4341.6, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 31.92% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.
J B Chemicals & Pharmaceuticals Ltd up for third straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2141, up 2.22% on the day as on 12:49 IST on the NSE. The stock is up 39.32% in last one year as compared to a 1.62% jump in NIFTY and a 12.19% jump in the Nifty Pharma index.
Zydus Lifesciences Ltd rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 934.15, up 2.4% on the day as on 12:49 IST on the NSE. The stock is up 5.42% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.